Asked by: James Naish (Labour - Rushcliffe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has plans to review allergen labelling requirements for non-prepacked foods and beverages; and whether he plans to take steps to implement the Food Standards Agency's recommendations for improving allergen information at the point of sale.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Food Standards Agency (FSA) has policy responsibility for food safety, including food allergen labelling, in England, Wales, and Northern Ireland, and is working to improve the availability and accuracy of allergen information for non-prepacked foods, which includes foods made to order in restaurants.
In December 2023, the FSA Board agreed that businesses selling non-prepacked foods, such as cafes and restaurants, should provide allergen information to consumers in writing, and that this should be supported by a conversation. Following the Board’s decision, FSA officials are working to assess the impact of different legislative options for improving the provision of allergen information for non-prepacked foods.
Officials in the Department for Environment, Food and Rural Affairs and the Department of Health and Social Care are being kept closely informed on the progress of this work.
In parallel, taking a steer from the Board, the FSA has created best practice guidance for businesses to provide written allergen information and support this with a conversation, which has recently been through a public consultation. This guidance, along with tools to assist businesses in following it, will be published shortly.
Asked by: James Naish (Labour - Rushcliffe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what NHS guidance and training is available to ensure Complex Regional Pain Syndrome is understood by medical professionals across England; and whether his Department plans to issue further guidance.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Congenital Anomaly and Rare Disease Registration Service (NCARDRS) is part of the National Disease Registration Service (NDRS) and NHS England. The NCARDRS aims to collect, curate, quality-assure, and analyse data from patients in England diagnosed and/or treated with rare conditions. Further information about the NCARDRS and the NDRS is available, respectively, at the following two links:
https://digital.nhs.uk/ndrs/about/ncardrs
Over the last five financial years, the National Institute for Health and Care Research has allocated £189,109 for research on Complex Regional Pain Syndrome (CRPS). Research has focused on establishing evidence–based management of CRPS to improve clinical outcomes throughout the care pathway.
There is a National Health Service conditions page dedicated to CRPS, detailing the symptoms, causes, diagnosis, and treatment pathway, which is available at the following link:
https://www.nhs.uk/conditions/complex-regional-pain-syndrome/
NHS England’s Genomics Education Programme and GeNotes resource provides concise information to help healthcare professionals make the right decisions at each stage of a clinical pathway. GeNotes also includes resources on non-genetic rare diseases, and work continues to expand the programme's coverage.
Asked by: James Naish (Labour - Rushcliffe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what data is collected on the prevalence of Complex Regional Pain Syndrome in England; and how this data is being used to understand the condition.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Congenital Anomaly and Rare Disease Registration Service (NCARDRS) is part of the National Disease Registration Service (NDRS) and NHS England. The NCARDRS aims to collect, curate, quality-assure, and analyse data from patients in England diagnosed and/or treated with rare conditions. Further information about the NCARDRS and the NDRS is available, respectively, at the following two links:
https://digital.nhs.uk/ndrs/about/ncardrs
Over the last five financial years, the National Institute for Health and Care Research has allocated £189,109 for research on Complex Regional Pain Syndrome (CRPS). Research has focused on establishing evidence–based management of CRPS to improve clinical outcomes throughout the care pathway.
There is a National Health Service conditions page dedicated to CRPS, detailing the symptoms, causes, diagnosis, and treatment pathway, which is available at the following link:
https://www.nhs.uk/conditions/complex-regional-pain-syndrome/
NHS England’s Genomics Education Programme and GeNotes resource provides concise information to help healthcare professionals make the right decisions at each stage of a clinical pathway. GeNotes also includes resources on non-genetic rare diseases, and work continues to expand the programme's coverage.
Asked by: James Naish (Labour - Rushcliffe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what research is being conducted on the (a) causes, (b) symptoms and (c) suitable treatments for Complex Regional Pain Syndrome.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Congenital Anomaly and Rare Disease Registration Service (NCARDRS) is part of the National Disease Registration Service (NDRS) and NHS England. The NCARDRS aims to collect, curate, quality-assure, and analyse data from patients in England diagnosed and/or treated with rare conditions. Further information about the NCARDRS and the NDRS is available, respectively, at the following two links:
https://digital.nhs.uk/ndrs/about/ncardrs
Over the last five financial years, the National Institute for Health and Care Research has allocated £189,109 for research on Complex Regional Pain Syndrome (CRPS). Research has focused on establishing evidence–based management of CRPS to improve clinical outcomes throughout the care pathway.
There is a National Health Service conditions page dedicated to CRPS, detailing the symptoms, causes, diagnosis, and treatment pathway, which is available at the following link:
https://www.nhs.uk/conditions/complex-regional-pain-syndrome/
NHS England’s Genomics Education Programme and GeNotes resource provides concise information to help healthcare professionals make the right decisions at each stage of a clinical pathway. GeNotes also includes resources on non-genetic rare diseases, and work continues to expand the programme's coverage.